Literature DB >> 8388541

The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element.

R Xu1, J Teng, T A Cooper.   

Abstract

We have characterized a novel positive-acting splicing element within the developmentally regulated alternative exon (exon 5) of the cardiac troponin T (cTNT) gene. The exon splicing element (ESE) is internal to the exon portions of the splice sites and is required for splicing to the 3' splice site but not the 5' splice site flanking the exon. Sequence comparisons between cTNT exon 5 and other exons that contain regions required for splicing reveal a common purine-rich motif. Sequence within cTNT exon 5 or a synthetic purine-rich motif facilitates splicing of heterologous alternative and constitutive splice sites in vivo. Interestingly, the ESE is not required for the preferential inclusion of cTNT exon 5 observed in primary skeletal muscle cultures. Our results strongly suggest that the purine-rich ESE serves as a general splicing element that is recognized by the constitutive splicing machinery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388541      PMCID: PMC359835          DOI: 10.1128/mcb.13.6.3660-3674.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

1.  Identification of exon sequences and an exon binding protein involved in alternative RNA splicing of calcitonin/CGRP.

Authors:  G J Cote; D T Stolow; S Peleg; S M Berget; R F Gagel
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

2.  A role for exon sequences and splice-site proximity in splice-site selection.

Authors:  R Reed; T Maniatis
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

3.  The length but not the sequence of the polyoma virus late leader exon is important for both late RNA splicing and stability.

Authors:  G R Adami; G G Carmichael
Journal:  Nucleic Acids Res       Date:  1987-03-25       Impact factor: 16.971

4.  Exon mutations that affect the choice of splice sites used in processing the SV40 late transcripts.

Authors:  M B Somasekhar; J E Mertz
Journal:  Nucleic Acids Res       Date:  1985-08-12       Impact factor: 16.971

5.  Spontaneous splicing mutations at the dihydrofolate reductase locus in Chinese hamster ovary cells.

Authors:  P J Mitchell; G Urlaub; L Chasin
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  The role of nucleotide sequences in splice site selection in eukaryotic pre-messenger RNA.

Authors:  L P Eperon; J P Estibeiro; I C Eperon
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

8.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

9.  The chicken fast skeletal troponin I gene: exon organization and sequence.

Authors:  W Nikovits; G Kuncio; C P Ordahl
Journal:  Nucleic Acids Res       Date:  1986-04-25       Impact factor: 16.971

10.  Signals for the selection of a splice site in pre-mRNA. Computer analysis of splice junction sequences and like sequences.

Authors:  Y Ohshima; Y Gotoh
Journal:  J Mol Biol       Date:  1987-05-20       Impact factor: 5.469

View more
  105 in total

1.  Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5' or 3' splice site activation.

Authors:  C F Bourgeois; M Popielarz; G Hildwein; J Stevenin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.

Authors:  X Li; M E Shambaugh; F M Rottman; J A Bokar
Journal:  RNA       Date:  2000-12       Impact factor: 4.942

3.  The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.

Authors:  Y Cavaloc; C F Bourgeois; L Kister; J Stévenin
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

4.  Alternative splicing of U12-dependent introns in vivo responds to purine-rich enhancers.

Authors:  R C Dietrich; G C Shukla; J D Fuller; R A Padgett
Journal:  RNA       Date:  2001-10       Impact factor: 4.942

5.  Multiple features contribute to efficient constitutive splicing of an unusually large exon.

Authors:  S R Bruce; M L Peterson
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

6.  Multiple interdependent sequence elements control splicing of a fibroblast growth factor receptor 2 alternative exon.

Authors:  F Del Gatto; A Plet; M C Gesnel; C Fort; R Breathnach
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

7.  B-cell and plasma-cell splicing differences: a potential role in regulated immunoglobulin RNA processing.

Authors:  Shirley R Bruce; R W Cameron Dingle; Martha L Peterson
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

Review 8.  Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression.

Authors:  Zhi-Ming Zheng
Journal:  J Biomed Sci       Date:  2004 May-Jun       Impact factor: 8.410

9.  A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.

Authors:  M P Wentz; B E Moore; M W Cloyd; S M Berget; L A Donehower
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

10.  A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly.

Authors:  Z M Zheng; M Huynen; C C Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.